Records containing: Parkinson's Disease Psychosis

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2026-02-27
A Multi-Center, Placebo-Controlled, Double-Blind Trial to Examine the Safety and Efficacy of Pimavanserin in the Treatment of Psychosis in Parkinson's Disease
CLINICAL_TRIALS study record update · 2025-09-09
A Pragmatic Randomized Trial Comparing Antipsychotics in Lewy Body Disease
CLINICAL_TRIALS study record update · 2025-08-28
CSP #2015 - Multicenter, Randomized, Double-blind Comparator Study of Antipsychotics Pimavanserin and Quetiapine for Parkinson''s Disease Psychosis (C-SAPP)
CLINICAL_TRIALS study record update · 2020-11-23
An Open-Label Safety Study of Pimavanserin in Parkinson's Disease Patients
CLINICAL_TRIALS study record update · 2019-06-24
A Multi-Center, Open-Label Extension Study to Examine the Safety and Tolerability of ACP-103 in the Treatment of Psychosis in Parkinson's Disease
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2017-04-18
Expanded Access Program of Pimavanserin in Patients With Parkinson's Disease Psychosis
CLINICAL_TRIALS study record update · 2014-09-09
ClinicalTrials.gov study NCT00658567
CLINICAL_TRIALS study record update · 2014-03-26
A Multi-Center, Placebo-Controlled, Double-Blind Trial to Examine the Safety and Efficacy of Pimavanserin in the Treatment of Psychosis in Parkinson's Disease
CLINICAL_TRIALS study record update · 2014-03-26
A Multi-Center, Placebo-Controlled, Double-Blind Trial to Examine the Safety and Efficacy of ACP-103 in the Treatment of Psychosis in Parkinson's Disease